$CROX

Crocs stock soars 19% on earnings beat and raised guidance

Crocs, Inc. (CROX) reported Q3 earnings of $3.69 per share, beating estimates by $0.39, with revenue at $1.04 billion, up 4.6% YoY. The company raised full-year 2026 guidance to $14.45-$14.65 EPS and expects 3% revenue growth. Shares surged 19.41% in pre-market trading. Adjusted operating margin expanded to 22.3% from 20.8% YoY, and the company repurchased 2.0 million shares for $250 million.

Original reporting
Published Oct 29, 2026, 12:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 12:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CROX
Bullish
high confidence
Mentioned
$CROX
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CROXBullishHigh
01

Why it matters

The earnings beat and guidance raise are primary disclosures that moved the stock sharply, offering a clear trading catalyst.

02

Market read

The news provides a fresh, material catalyst for CROX and signals strength in the consumer discretionary sector.

03

What to watch

Potential supply‑chain constraints or macro‑economic headwinds could temper growth.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Crocs announced Q3 results with EPS $3.69 vs $3.30 consensus and revenue $1.04B vs $1.00B estimate, plus a full‑year EPS outlook of $14.45‑$14.65.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Crocs reported Q3 earnings beat and raised full-year guidance, sending the stock up 19% pre‑market.

Expected impact

likely upward pressure as investors price in higher earnings and guidance

Evidence & confidence

The earnings beat and guidance raise are fresh, material facts for a mid‑cap stock, and the 19% pre‑market rally confirms market reaction.

Market effects

Footwear and casual apparel sector may see uplift as Crocs demonstrates demand resilience.

U.S. consumer discretionary sentiment supported by the beat.

Limited to investors tracking U.S. consumer stocks.

Counterpoint

If the guidance is overly optimistic, a pull‑back could occur once detailed guidance is scrutinized.

Key entities

  • Crocs, Inc.

    Footwear manufacturer listed on NASDAQ.

Related articles

$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

$CROXMed

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.